DELCATH SYSTEMS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
DELCATH SYSTEMS, INC. (DCTH) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 70.50% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-08-06
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2026-03-31 was 70.50%, a 21.67% decline year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-03-31 was 90.00%, a 21.74% decline year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 115.00%, a 33.45% decline year-over-year.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-03-31 was 172.80%.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2020 was 181.00%, a 22.60% increase from fiscal 2019.
- DELCATH SYSTEMS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2019 was 147.63%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 70.50% 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | 70.50% 10-Q · filed 2026-05-07 | ||||
| 2025-09-30 | 89.10% 10-Q · filed 2025-11-04 | ||||
| 2025-06-30 | 89.20% 10-Q · filed 2026-08-06 | ||||
| 2025-03-31 | 90.00% 10-Q · filed 2026-05-07 | ||||
| 2024-09-30 | 114.00% 10-Q · filed 2025-11-04 | ||||
| 2024-06-30 | 114.30% 10-Q · filed 2025-08-06 | ||||
| 2024-03-31 | 115.00% 10-Q · filed 2025-05-08 | ||||
| 2023-09-30 | 160.40% 10-Q · filed 2024-11-08 | ||||
| 2023-06-30 | 161.60% 10-Q · filed 2024-08-05 | ||||
| 2023-03-31 | 172.80% 10-Q · filed 2024-05-14 | ||||
| 2022-09-30 | 164.30% 10-Q · filed 2023-11-13 | ||||
| 2021-08-06 | 187.00% 10-K · filed 2023-03-27 | ||||
| 2021-06-30 | 178.33% 10-Q · filed 2022-08-08 | ||||
| 2020-12-31 | 181.00% 10-K · filed 2022-03-31 | ||||
| 2019-12-31 | 147.63% 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| CARLSMED, INC. (CARL) | United States | $0.405B |